Gianluca Gaidano Selected Research

Gianluca Gaidano Research Topics

Disease

82	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2022 - 05/2002
64	Neoplasms (Cancer) 06/2022 - 01/2002
31	Lymphoma (Lymphomas) 01/2021 - 07/2002
26	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2002
17	Multiple Myeloma 01/2022 - 05/2002
13	Disease Progression 12/2021 - 08/2003
12	B-Cell Lymphoma (Lymphoma, B Cell) 12/2021 - 01/2003
12	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2014 - 11/2003
9	COVID-19 11/2022 - 07/2020
8	Leukemia 01/2022 - 10/2011
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 02/2012
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 03/2011
6	Infections 01/2022 - 08/2003
6	Residual Neoplasm 12/2021 - 09/2014
6	Hemorrhage 01/2021 - 06/2004
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 02/2006
5	Neutropenia 01/2021 - 09/2015
5	Thrombocytopenia (Thrombopenia) 12/2018 - 06/2014
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2015 - 12/2002
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 02/2012
4	Acquired Immunodeficiency Syndrome (AIDS) 03/2007 - 01/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2016
3	Hypoxia (Hypoxemia) 01/2020 - 11/2016
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2018 - 11/2013
3	Lymphocytosis 01/2018 - 06/2009
3	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 05/2002
3	Pneumonia (Pneumonitis) 04/2016 - 09/2015
3	Fatigue 12/2015 - 02/2015
3	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2004 - 01/2002
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022 - 02/2004
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2012
2	Hairy Cell Leukemia 01/2021 - 05/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 10/2015
2	Injection Site Reaction 01/2019 - 11/2015

Drug/Important Bio-Agent (IBA)

34	Rituximab (Mabthera)FDA Link 01/2022 - 12/2002
20	Biological ProductsIBA 01/2022 - 05/2002
19	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2002
17	ibrutinibIBA 06/2022 - 03/2014
15	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 05/2002
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2002
10	Lenalidomide (CC 5013)FDA Link 01/2021 - 11/2013
10	fludarabineIBA 01/2020 - 12/2011
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2012
9	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
9	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2003
8	Bendamustine Hydrochloride FDA Link 01/2021 - 07/2012
8	AntigensIBA 01/2019 - 12/2006
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2003
8	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018 - 05/2002
7	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 01/2003
6	LigandsIBA 04/2022 - 02/2003
6	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2016
5	Circulating Tumor DNAIBA 06/2022 - 01/2018
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 09/2004
5	Bortezomib (Velcade)FDA Link 10/2017 - 12/2010
5	Azacitidine (5 Azacytidine)FDA Link 04/2016 - 02/2012
4	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2017
4	carfilzomibIBA 01/2021 - 01/2016
4	Monoclonal AntibodiesIBA 01/2021 - 12/2002
4	Phosphotransferases (Kinase)IBA 01/2021 - 04/2015
4	Chlorambucil (Leukeran)FDA Link 01/2020 - 12/2015
4	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 07/2010
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2003
3	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 06/2004
3	idelalisibIBA 08/2021 - 01/2019
3	tafasitamabIBA 01/2021 - 01/2020
3	obinutuzumabIBA 01/2020 - 10/2015
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2011
3	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2011
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 04/2015
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018 - 06/2010
3	Alemtuzumab (Campath)FDA Link 11/2015 - 12/2002
3	CytokinesIBA 01/2015 - 05/2008
3	Thalidomide (Thalomid)FDA Link 10/2014 - 07/2010
3	MethyltransferasesIBA 09/2009 - 01/2002
3	Death-Associated Protein KinasesIBA 09/2009 - 11/2003
2	IntegrinsIBA 04/2022 - 01/2016
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2022 - 05/2009
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2019
2	Investigational DrugsIBA 01/2021 - 05/2017
2	ofatumumab FDA Link 11/2018 - 12/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 02/2004
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2018 - 12/2016
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2018 - 12/2014
2	romiplostim FDA Link 03/2018 - 06/2014

Therapy/Procedure

52	Therapeutics 11/2022 - 12/2002
16	Drug Therapy (Chemotherapy) 11/2022 - 01/2003
9	Stem Cell Transplantation 01/2021 - 09/2009
6	Organ Transplantation 05/2010 - 11/2003
5	Transplantation 01/2019 - 03/2014
4	Precision Medicine 10/2021 - 01/2020
3	Time-to-Treatment 04/2015 - 01/2010
2	Radiotherapy 12/2020 - 01/2003
2	Autologous Transplantation 01/2020 - 04/2016
2	Hematopoietic Stem Cell Transplantation 01/2019 - 12/2009
2	Drug Tapering 12/2018 - 01/2017
2	Platelet Transfusion (Blood Platelet Transfusions) 03/2018 - 06/2014